D E Wilcox

Author PubWeight™ 24.03‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature 1986 4.13
2 Nitric oxide hemoglobin in patients receiving nitroglycerin as detected by electron paramagnetic resonance spectroscopy. J Lab Clin Med 1992 1.45
3 Duchenne muscular dystrophy due to familial Xp21 deletion detectable by DNA analysis and flow cytometry. Hum Genet 1986 1.16
4 Utilization prediction for helicopter emergency medical services. Ann Emerg Med 1987 1.12
5 Properties of the Sp1 zinc finger 3 peptide: coordination chemistry, redox reactions, and metal binding competition with metallothionein. Chem Res Toxicol 1995 0.97
6 More on reliability of death certificates. N Engl J Med 1981 0.96
7 Bioactivation of nitroprusside by porcine endothelial cells. Toxicol Appl Pharmacol 1994 0.95
8 Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995 0.91
9 Multipoint linkage analysis of the short arm of the human X chromosome in families with X-linked muscular dystrophy. Hum Genet 1985 0.91
10 Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy. Circ Res 1990 0.89
11 Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart 2007 0.89
12 Isothermal titration calorimetry measurements of Ni(II) and Cu(II) binding to His, GlyGlyHis, HisGlyHis, and bovine serum albumin: a critical evaluation. Inorg Chem 2000 0.88
13 X-linked and FSH dystrophies in one family. Neuromuscul Disord 1991 0.88
14 Analysis of Scottish Duchenne and Becker muscular dystrophy families with dystrophin cDNA probes. J Med Genet 1990 0.88
15 Spectroscopic studies of nitric oxide (NO) interactions with cobalamins: reaction of NO with superoxocobalamin(III) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 1998 0.84
16 Effects of metal ions on the oxidation and nitrosation of cysteine residues in proteins and enzymes. Met Ions Biol Syst 2001 0.83
17 Calorimetric investigation of phosphorylated and non-phosphorylated peptide ligand binding to the human Grb7-SH2 domain. J Mol Recognit 2007 0.80
18 Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilators. Toxicol Appl Pharmacol 1987 0.80
19 Effects of temperature, oxygen, heme ligands and sulfhydryl alkylation on the reactions of nitroprusside and nitroglycerin with hemoglobin. Biochem Pharmacol 1993 0.79
20 Direct measurement of dimensional accuracy with three denture-processing techniques. Int J Prosthodont 1992 0.78
21 Toxicology of selected nitric oxide-donating xenobiotics, with particular reference to azide. Crit Rev Toxicol 1994 0.77
22 Nitrite conversion to nitric oxide in red cells and its stabilization as a nitrosylated valency hybrid of hemoglobin. J Pharmacol Exp Ther 1987 0.76
23 Palmoplantar keratoderma, nail dystrophy, and hereditary motor and sensory neuropathy: an autosomal dominant trait. J Med Genet 1988 0.75
24 Decomposition and specific exchange of the trans-cyanide ligand on nitroprusside is facilitated by hemoglobin. Toxicol Appl Pharmacol 1989 0.75
25 Legislative reform needed to strengthen obligations of driving. Ann Emerg Med 1984 0.75
26 An audio urine-glucose analyzer for blind diabetics. Diabetes 1977 0.75
27 The nature of the binuclear copper site in Limulus and other hemocyanins. Prog Clin Biol Res 1982 0.75
28 A unique low frequency Raman band associated with metal binding to metallothionein. Biochem Biophys Res Commun 1989 0.75
29 Generation of valency hybrids and nitrosylated species of hemoglobin in mice by nitric oxide vasodilators. Toxicol Appl Pharmacol 1988 0.75
30 The Kansas Secondary Rheumatic Fever Program. Past, present and future. J Kans Med Soc 1972 0.75
31 Nitroprusside: a potpourri of biologically reactive intermediates. Adv Exp Med Biol 1991 0.75
32 Embryotoxic effects of sodium azide infusions in the Syrian hamster. Fundam Appl Toxicol 1990 0.75
33 An impurity present in some samples of SIN-1 oxidizes it to nitric oxide in anaerobic solutions. Toxicology 1994 0.75
34 Inhibition of potato polyphenol oxidase by anions and activity in various carboxylate buffers (pH 4.8) at constant ionic strength. J Enzyme Inhib 2001 0.75